AIDS
- DEVENDRA A, Kohler M, Letsika M, Khooa H, et al
HIV viral suppression in children and adolescents two years after transition to
dolutegravir: a multicentre cohort study.
AIDS. 2024 Jan 10. doi: 10.1097/QAD.0000000000003835.
AIDS Res Hum Retroviruses
- LAUFER N, Bouzas MB, Fernandez-Giuliano S, Zapiola I, et al
Pretreatment HIV-1 Resistance in Argentina: results from the second surveillance
study following WHO guidelines (2019).
AIDS Res Hum Retroviruses. 2024 Feb 22. doi: 10.1089/AID.2023.0083.
- XU K, Chen J, Zhu M, Zhang X, et al
Exploring HIV-1 transmission features among older individuals in developed
eastern China.
AIDS Res Hum Retroviruses. 2024 Feb 22. doi: 10.1089/AID.2023.0066.
- DUBE K, Perez-Brumer A, Patel H, Zhou C, et al
"This is actually a really unique moment in time": Navigating Long-Acting HIV
Treatment and HIV Cure Research with Analytical Treatment Interruptions - A
Qualitative Interview Study in the United States.
AIDS Res Hum Retroviruses. 2024 Feb 22. doi: 10.1089/AID.2023.0105.
- GULER E, Arikan Sarioglu A, Sultanoglu N, Suer K, et al
Molecular Epidemiology of HIV-1 Subtypes and Primary Antiretroviral Resistance
Profiles in Northern Cyprus: First Data Series.
AIDS Res Hum Retroviruses. 2024 Feb 17. doi: 10.1089/AID.2023.0021.
- KHAYUMBI J, Sasser L, McLaughlin T, Muchiri B, et al
Active tuberculosis is associated with depletion of HIV-specific CD4 and CD8 T
cells in people with HIV.
AIDS Res Hum Retroviruses. 2024 Feb 17. doi: 10.1089/AID.2023.0088.
- SACHDEVA RK, Naidu G, Chauhan P, Kharbanda S, et al
CSF viral escape on HAART: Analysis from single tertiary care centre.
AIDS Res Hum Retroviruses. 2024 Feb 17. doi: 10.1089/AID.2022.0187.
Antimicrob Agents Chemother
- MULATO A, Lansdon E, Aoyama R, Voigt J, et al
Preclinical characterization of a non-peptidomimetic HIV protease inhibitor with
improved metabolic stability.
Antimicrob Agents Chemother. 2024 Feb 21:e0137323. doi: 10.1128/aac.01373.
Antivir Ther
- LEPIK KJ, Hunt OL, Bacani N, Wang L, et al
Adverse drug reactions attributed to generic substitution of antiretroviral
medications among HIV treatment and pre-exposure prophylaxis clients in British
Columbia, Canada.
Antivir Ther. 2024;29:13596535241233128.
BMC Cancer
- TAN R, Zhu X, Sun Y, Yang S, et al
The association of HBV infection and head and neck cancer: a systematic review
and meta-analysis.
BMC Cancer. 2024;24:225.
- NAKIGOZI H, Ndejjo R, Bazeyo W, Nabaggala A, et al
Prevalence of genital high-risk human papillomavirus infections and associated
factors among women living with human immunodeficiency virus in Uganda.
BMC Cancer. 2024;24:243.
Cell
- ARMANI-TOURRET M, Gao C, Hartana CA, Sun W, et al
Selection of epigenetically privileged HIV-1 proviruses during treatment with
panobinostat and interferon-alpha2a.
Cell. 2024 Feb 16:S0092-8674(24)00105-3. doi: 10.1016/j.cell.2024.
Clin Infect Dis
- AGGARWAL NR, Nordwall J, Braun DL, Chung L, et al
Viral and Host Factors Are Associated With Mortality in Hospitalized Patients
With COVID-19.
Clin Infect Dis. 2024 Feb 20:ciad780. doi: 10.1093.
HIV Med
- KLEEBAYOON A, Wiwanitkit V
Asymptomatic monkeypox infection and highly sexually active MSM population.
HIV Med. 2024 Feb 20. doi: 10.1111/hiv.13623.
- RAMOS-RUPERTO L, Arcos-Rueda MDM, de Miguel-Buckley R, Busca-Arenzana C, et al
Sex differences in the effectiveness and tolerability of dolutegravir plus
rilpivirine as a switch strategy in people living with HIV.
HIV Med. 2024 Feb 20. doi: 10.1111/hiv.13617.
- HOLROYD KB, Han WM, Apornpong T, Trautmann L, et al
Framingham risk score based vascular outcomes in acute versus chronic HIV cohorts
after 6 years of ART.
HIV Med. 2024 Feb 21. doi: 10.1111/hiv.13621.
Int J Dermatol
- TYAGI M, Verma V, Bhari N, Gupta S, et al
Herpes presenting as pyoderma gangrenosum-like ulcers in a child with AIDS.
Int J Dermatol. 2024;63:371-373.
J Acquir Immune Defic Syndr
- GRIESEL R, Banda CG, Zhao Y, Omar Z, et al
PHARMACOKINETICS OF SINGLE VERSUS DOUBLE-DOSE DOLUTEGRAVIR AFTER SWITCHING FROM A
FAILING EFAVIRENZ-BASED REGIMEN.
J Acquir Immune Defic Syndr. 2024 Feb 15. doi: 10.1097/QAI.0000000000003402.
J Clin Invest
- GASCA-CAPOTE C, Lian X, Gao C, Roseto IC, et al
The HIV-1 reservoir landscape in persistent elite controllers and transient elite
controllers.
J Clin Invest. 2024 Feb 20:e174215. doi: 10.1172/JCI174215.
J Infect Dis
- PIHL RMF, Smith-Mahoney EL, Olson A, Yuen RR, et al
Distinct subsets of Vdelta1 effector and Vdelta2 gammadelta T cells shift in frequency and are
linked to plasma inflammatory markers during ART-suppressed HIV infection.
J Infect Dis. 2024 Feb 23:jiae091. doi: 10.1093.
- THIELE RJ, Grunhagel B, Muenchhoff M, Pujantell-Graell M, et al
Magnitude of Type I Interferon Responses by Plasmacytoid Dendritic Cells After
TLR7 Stimulation Is Associated With Human Immunodeficiency Virus Type 1 (HIV-1)
Reservoir Sizes in Cisgender Women With HIV-1 on Antiretroviral Therapy.
J Infect Dis. 2024 Feb 22:jiae013. doi: 10.1093.
- SHIAU S, Zumpano F, Wang Z, Shah J, et al
Epigenetic Aging and Musculoskeletal Outcomes in a Cohort of Women Living With
HIV.
J Infect Dis. 2024 Feb 15:jiae016. doi: 10.1093.
J Med Virol
- XU Y, Jiao K, Zhang Y, Huang S, et al
Behavioral intentions of self-isolation and informing close contacts after
developing mpox-related symptoms among young men who have sex with men in China.
J Med Virol. 2024;96:e29470.
- DEL PINO M, Vorsters A, Joura EA, Doorbar J, et al
Risk factors for human papillomavirus infection and disease: A targeted
literature summary.
J Med Virol. 2024;96:e29420.
- SERWIN K, Scheibe K, Urbanska A, Aksak-Was B, et al
Phylodynamic evolution of HIV-1 A6 sub-subtype epidemics in Poland.
J Med Virol. 2024;96:e29482.
J Virol
- FENTON AD, Archin N, Turner A-M, Joseph S, et al
A novel high-throughput microwell outgrowth assay for HIV-infected cells.
J Virol. 2024 Feb 20:e0179823. doi: 10.1128/jvi.01798.
Lancet
- JOHNSTONE F
Picture an epidemic: contemporary culture and HIV.
Lancet. 2024 Feb 13:S0140-6736(24)00252-6. doi: 10.1016/S0140-6736(24)00252.
Lancet Infect Dis
- ALLAN-BLITZ LT, Fifer H, Klausner JD
Managing treatment failure in Neisseria gonorrhoeae infection: current guidelines
and future directions.
Lancet Infect Dis. 2024 Feb 14:S1473-3099(24)00001.
PLoS Med
- SEMITALA FC, Kadota JL, Musinguzi A, Welishe F, et al
Comparison of 3 optimized delivery strategies for completion of
isoniazid-rifapentine (3HP) for tuberculosis prevention among people living with
HIV in Uganda: A single-center randomized trial.
PLoS Med. 2024;21:e1004356.
- MATHUR S, Smuk M, Evans C, Wedderburn CJ, et al
Estimating the impact of alternative programmatic cotrimoxazole strategies on
mortality among children born to mothers with HIV: A modelling study.
PLoS Med. 2024;21:e1004334.
PLoS One
- RUNGMAITREE S, Werarak P, Pumpradit W, Phongsamart W, et al
A pilot program of HIV pre-exposure prophylaxis in Thai youth.
PLoS One. 2024;19:e0298914.
- MUDRA RAKSHASA-LOOTS A, Naidoo S, Hamana T, Fanqa B, et al
Multi-modal analysis of inflammation as a potential mediator of depressive
symptoms in young people with HIV: The GOLD depression study.
PLoS One. 2024;19:e0298787.
- LIKOTI PG, Kuupiel D, Khuzwayo N
Mapping factors influencing initiation of antiretroviral treatment among
adolescents living with HIV/AIDS in sub-Saharan Africa: A scoping review
protocol.
PLoS One. 2024;19:e0289515.
- MESIC A, Decroo T, Mar HT, Jacobs BKM, et al
Correction: Viraemic-time predicts mortality among people living with HIV on
second-line antiretroviral treatment in Myanmar: A retrospective cohort study.
PLoS One. 2024;19:e0299460.
- NYMAN F
Reshaping the narrative: Tracing the historical trajectory of HIV/AIDS, gay men,
and public health in Sweden.
PLoS One. 2024;19:e0298630.
- KAMAU SG, Akatusasira R, Namatovu A, Kibet E, et al
The level of antiretroviral therapy (ART) adherence among orphan children and
adolescents living with HIV/AIDS: A systematic review and meta-analysis.
PLoS One. 2024;19:e0295227.
- STANTON AM, Boyd RL, O'Cleirigh C, Olivier S, et al
HIV, multimorbidity, and health-related quality of life in rural KwaZulu-Natal,
South Africa: A population-based study.
PLoS One. 2024;19:e0293963.
- CONAN N, Simons E, Chihana ML, Ohler L, et al
Correction: Increase in HIV viral suppression in KwaZulu-Natal, South Africa:
Community-based cross sectional surveys 2018 and 2013. What remains to be done?
PLoS One. 2024;19:e0299408.
Free Medical Abstracts
Privacy Policy
Sponsors
Share
© Amedeo 1997-2016